TAG:
cytology laboratory
May 06, 2013 “Intelligence: Late Breaking Lab News”
Much is happening in the anatomic pathology market in the Pacific Northwest. PAML, LLC (Spokane, Washington), and CellNetix (Seattle, Washington) finally executed the agreement whereby PAML made an equity investment in CellNetix. Now, the two lab companies will collaborate on developing…
August 15, 2011 “Intelligence: Late Breaking Lab News”
Last Friday, the acquisition of Southern Diagnostic Laboratories, Inc., of Birmingham, Alabama, was announced by Solstas Lab Partners of Greensboro, North Carolina. Steve Boyd, who is the Founder and CEO of Southern Diagnostics, will become a Senior Vice President at…
Inaccurate Results + Quest Dominates News Cycle
CEO SUMMARY: Most laboratory professionals donāt know it yet, but significant changes occurred to the entire lab industry last week. After Quest Diagnostics Incorporated acknowledged that it was retesting tens of thousands of patients because 7% of the Vitamin D results it repo…
Cytology Lab Uses Lean to Simplify Processes
CEO SUMMARY: Like many labs today, the gynecologic cytology laboratory at the University of Iowa Hospitals and Clinics had a pre- and post-analytical work flow with many complex steps. This work flowāheavily influenced by a legacy of previous information systemsāwas inefficient, conta…
SBCL Makes System-Wide Commitment To AutoPap
SOMEONE ALWAYS HAS TO BE FIRST to adopt new technology. In the case of automated cytology, it will be SmithKline Beecham Clinical Laboratories (SBCL). SBCL and NeoPath, Inc. announced a four-year national agreement between the two companies on October 9 which will e…
AutoCyte Moves One Step Closer To FDA Approval
CEO SUMMARY: Until now, AutoCyte has kept a relatively quiet presence in the automated cytology marketplace. That may soon change as the FDA takes action on the companyās PREPā¢ and SCREENā¢ products. AutoCyte expects these products will boost productivity and quality in cytology labs…
Pap Smear Technologies Battle For Market Share
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…
Unilab Pushes Insurers To Increase Cap Rates
CEO SUMMARY: Californiaās financially destructive capitation rates plunged two more laboratories into bankruptcy. Unilabās actions indicate that even the largest laboratory company in the state can no longer survive without reimbursement relief. The question remains as to whether mana…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.